Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US Farhat Nasim2 May 2019 10:00 AM ISTDengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis Farhat Nasim26 April 2019 12:49 PM ISTLeflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution Farhat Nasim22 April 2019 11:55 AM ISTTeriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
CDSCO expert committee suggests ban of yet another 324 FDCs Meghna A Singhania15 April 2019 11:49 AM ISTNew Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
Pfizer, GSK consumer healthcare venture to focus on China, US market Farhat Nasim7 April 2019 9:14 AM ISTLONDON: The United States and China will be key focuses for the consumer healthcare venture being formed by GlaxoSmithKline and Pfizer, as the...
Setback: USFDA rejects Sanofi, Lexicon Sotagliflozin for type 1 diabetes Farhat Nasim24 March 2019 9:45 AM ISTThe decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin,...
Sanofi officials to be charged over dengue vaccine deaths Farhat Nasim3 March 2019 9:45 AM ISTMANILA: The Philippine Department of Justice on Friday said it had found probable cause to indict officials from French drugmaker Sanofi and former...
Setback to Sanofi: Court refuses to quash corruption case, directs CBI to continue inquiry Meghna A Singhania18 Feb 2019 6:03 PM ISTIt was alleged that BARC employees reportedly influenced the selection of tenders for the purchase of drugs. They illegally favoured Sanofi and...
Biomunex signs licensing agreement with Sanofi for development of antibodies Medical Dialogues Bureau19 Jan 2019 9:15 AM ISTUnder the terms of the agreement, Sanofi will have access to Biomunex proprietary technology to generate and optimize bi- and multi-specific antibody...
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal Farhat Nasim9 Jan 2019 9:15 AM ISTSanofi will pay Regeneron $462 million representing the balance of payments due under their original deal, which covers the Sanofi share of the...
Dengue vaccine should be approved: European Medicines Agency Medical Dialogues Bureau20 Oct 2018 3:03 PM ISTLONDON - Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a...
Sanofi to invest 432.4 million dollars in Canada vaccine facility Ruby Khatun Khatun14 April 2018 9:45 AM ISTPARIS: French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would...
